SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,748.31 595.45
( 0.78%)

Global Indices

Nasdaq

53,682.77 599.82
(1.13%)

Dow Jones

7,765.55 77.95
(1.01%)

Hang Seng

64,337.38 11.74
(0.02%)

Nikkei 225

10,831.87 75.42
(0.70%)

Forex

USD-INR

94.73 -0.22
(-0.23%)

EUR-INR

109.71 -0.40
(-0.36%)

GBP-INR

127.83 -0.65
(-0.50%)

JPY-INR

0.59 0.00
(0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Advanced Enzyme Technologies Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

540025

INE837H01020

63.3529756

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ADVENZYMES

39.95

3310.57

EPS(TTM)

Face Value()

Div & Yield %

7.4

1.81

Back

Antarctica standalone net profit declines 20.29% in the June 2026 quarter

Aug 15,2026

Net profit of Antarctica declined 20.29% to Rs 0.55 crore in the quarter ended June 2026 as against Rs 0.69 crore during the previous quarter ended June 2025. Sales rose 709.82% to Rs 40.41 crore in the quarter ended June 2026 as against Rs 4.99 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	40.41	4.99	710
OPM %	1.46	20.24	-
PBDT	0.59	1.01	-42
PBT	0.59	0.74	-20
NP	0.55	0.69	-20

76,748.31 595.45 ( 0.78%)

53,682.77 599.82 (1.13%)

7,765.55 77.95 (1.01%)

64,337.38 11.74 (0.02%)

10,831.87 75.42 (0.70%)

94.73 -0.22 (-0.23%)

109.71 -0.40 (-0.36%)

127.83 -0.65 (-0.50%)

0.59 0.00 (0.14%)